Background
Cristina Adriana Popa
Why-dralazine?! Population risk of drug induced ...

This week, we will discuss why a large registry cohort was needed to move past decades of scattered case reports and clarify the true risk of hydralazine‑associated vasculitis. When rare events hide in noise, only scale can reveal the signal. Can population‑level data finally bring this paradox into focus?

Why-dralazine?! Population risk of drug induced vasculitis
Background
Cristina Adriana Popa
From missed opportunities to equitable access: ...

Summary of the STEPS trial which will be a twitter spaces discussion

From missed opportunities to equitable access: Can STEPS redesign the kidney transplant pathway?
Background
Cristina Adriana Popa
Searchin’ For My Lost Shaker of Salt- Targeted ...

This week, we will discuss the HIT trial- a large randomized study challenging one of the most reflexive responses in hospital medicine: see hyponatremia, fix the sodium. But what if correcting the number doesn’t change what actually matters?

Searchin’ For My Lost Shaker of Salt- Targeted Treatment of Hyponatremia
news
swapnil hiremath
NephJC Covers LBCTs at the World Congress

The NephJC editors cover the simultaneous publication from the world congress

Background
Brian Rifkin
Is REACT (Renal Autologous Cell Therapy) the ...

This week, we will discuss the use of renal autologous cell therapy (REACT) in diabetic kidney disease.

Is REACT (Renal Autologous Cell Therapy) the “fifth pillar” in diabetic kidney disease?

twitter

Regarding the Situation with…Social Media in General

Regarding the Situation with…Twitter, Bluesky, Social Media

We at #NephJC pride ourselves on bringing you the best in nephrology publications and innovations without commercial bias. As we’ve stated during many a donation drive, we are beholden to none but our followers and readers.

Having said that, we’ve noticed a trend since the death of Twitter (yes, it will always be Twitter to the real FOAMed illuminati). The diaspora of NephTwitter were scattered throughout the nephro-universe of social media, never quite finding a new home. Perhaps the downfall of the Nephrologians can be a plot line for the next Mandalorian season?? Many left the social media space altogether because of the division, politicization and plain BS of some of the algorithms (I for one don’t need to see EVERYTHING Elon posts). However, we still believe there is a need for our unique style of nephrology education. Jon Stewart- yes, the comedian- recently likened social media to smoking: an addictive, attention seeking habit that is generally recognized as not healthy for most people and that is likely to be regulated for teen and self-regulate by adults. He believed the antidote was more long-form, nuanced edu-tainment. So, it light of the changing landscape, we are going to focus more on our blogs, VAs, and podcasts and less on live discussions on Bluesky.

NephJC is nothing if not nimble, and we have never been afraid of change.

So, given the low attendance at live chats (no judgement) we’re changing to a summary thread (a new 10 posts) with provocative questions to answer, at your leisure. We hope this keeps the discussions going without the need to be on social media for prolonged periods or at a specific hour and day. These threads will be posted at the familiar 9pm EST every other Tuesday. This shorter form will also allow us to post on multiple sites, and hopefully we will be easily accessible to you where you chat with other nephrophiles. Feel free to reply, chat, tag people in conversations whenever and wherever you see a #NephJC post. The team will be around, but we won’t be actively ‘moderating’ a one hour chat.

Sincerely,

NephJC Leadership


PS: As always we love to hear from our audience. If you have suggestions, or a better way to reach more people, we are all ears. Heck, if we hear enough complaints we might even bring back the chats!😉

Twitter Journal Clubs

Appendix 2 of the NephJC Primer on Twitter Journal Clubs contained a list of all known twitter journal clubs. This information used to be stored on the Wikipedia page on journal clubs, you can see it in the history. But Wikipedia, home of a comprehensive list of English Canadian game shows (we are not kidding, see French list here), did not think a list of Twitter journal clubs was encyclopedia worthy. So we are recreating the list here as a Google Sheet. Have at it.



,

The Neph-Twitterverse discovers Twitter polls

,

A few weeks ago, the folks at twitter announced they were rolling out Twitter polls. Previously, tweeps would use manually counting responses or the RT-if-you-agree Fav-if-you-don't approach. This is how the polls were supposed to work:

So what, you might say? A few users (notably @conradhackett from Pew research) played a lot with them, sample poll:

The ease of setting one up, and the option to just click and be done were some of the major selling points. But it wasn't clear if would be just a passing fad or something more. I used one at the #KidneyWk, but there were few responders

Then Matt decided to poll the #nephjc followers after the suPAR chat

And Thomas Hiemstra decided to design his next #DreamRCT on therapy for Membranous nephropathy with a series of tweets:

Second scenario

And it wasn't long before Graham Abra re-ran an older question on the utility of urine eosinophils in allergic interstitial nephritis

another one on the duration of steroids in SLE, in remission

So we guess polls on twitter are here to say. Nephrology tweeps find it awesome (and I can say so with confidence, backed by facts, or shall we say, a poll?)

Swapnil Hiremath

New kid on the block: #RheumJC

The rheumatology crew that killed it during the Rituximab for ANCA vasculitis NephJC are striking out on there own with an ambitious plan for their own twitter journal club. They are kicking it off this coming Thursday with a GMT and EST at the exact same time as our NephJCs, 8GMT and 9EST. They are then doing a consolidation wrap up discussion the following day. 

The first topic is one near and dear to all of our hearts, lupus nephritis. RCT of tacrolimus versus MMF for induction. 

It would be great if some of our community could support the rheumatologists as they launch their journal club.

RheumJC home page | Press coverage | Twitter feed